BOE Importance: 3/10

The Medicines Agency extends its agreement with patient organizations to promote safe drug use

13 Apr 2026 Effective: 30 Mar 2026 18 views
Who is affected:
Patient organizations, citizens who use medicines and healthcare sector

Summary

The AEMPS renews its agreement with the Patient Organizations Platform to promote rational medicine use and confidence in the European regulatory network.

Detailed analysis PRO

The Spanish Medicines and Health Products Agency (AEMPS) publishes the extension addendum to its agreement with the Patient Organizations Platform (POP). This agreement aims primarily to promote safe and rational use of medicines among citizens, as well as strengthen confidence in the Medicines Regulatory Network of th…

PRO exclusive content

Implicaciones prácticas, plazos y recomendaciones específicas para tu sector.

Crear cuenta gratis Ver planes PRO

Full official title

Resolución de 30 de marzo de 2026, de la Agencia Española de Medicamentos y Productos Sanitarios, por la que se publica la Adenda de prórroga del Convenio con la Plataforma de Organizaciones de Pacientes, en relación con el fomento del uso seguro y racional de los medicamentos y la confianza en la Red Reguladora de Medicamentos de la Unión Europea.

View original source (BOE)

Affected sectors

Healthcare

Categories

Tax & Revenue Labour & Employment Corporate & Business Data Protection Social Security European Regulations Grants & Subsidies Other Regulations Public Sector Education Energy Agriculture & Fisheries Real Estate

PRO Plan

Alerts, detailed analysis and private Telegram channel.

From 9.99 EUR/month

Related regulations